ATE67479T1 - Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien. - Google Patents

Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.

Info

Publication number
ATE67479T1
ATE67479T1 AT87108737T AT87108737T ATE67479T1 AT E67479 T1 ATE67479 T1 AT E67479T1 AT 87108737 T AT87108737 T AT 87108737T AT 87108737 T AT87108737 T AT 87108737T AT E67479 T1 ATE67479 T1 AT E67479T1
Authority
AT
Austria
Prior art keywords
esters
bronchopneumopathies
phlogistic
treatment
guajakol
Prior art date
Application number
AT87108737T
Other languages
English (en)
Inventor
Angelo Signor
Marino Nicolini
Original Assignee
Finteco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finteco Srl filed Critical Finteco Srl
Application granted granted Critical
Publication of ATE67479T1 publication Critical patent/ATE67479T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/90Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl and carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/14Preparation of carboxylic acid esters from carboxylic acid halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT87108737T 1986-07-03 1987-06-18 Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien. ATE67479T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8621021A IT1213579B (it) 1986-07-03 1986-07-03 Flogistica. esteri di salsalato con guaiacolo atti al trattamento di broncopneumapatie a base
EP87108737A EP0251039B1 (de) 1986-07-03 1987-06-18 Ester von Salsalat mit Guajakol zur Behandlung von phlogistischen Bronchopneumopathien

Publications (1)

Publication Number Publication Date
ATE67479T1 true ATE67479T1 (de) 1991-10-15

Family

ID=11175501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87108737T ATE67479T1 (de) 1986-07-03 1987-06-18 Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.

Country Status (7)

Country Link
US (1) US4743704A (de)
EP (1) EP0251039B1 (de)
JP (1) JPS6322541A (de)
AT (1) ATE67479T1 (de)
DE (1) DE3773059D1 (de)
ES (1) ES2026485T3 (de)
IT (1) IT1213579B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008007171A1 (en) 2006-07-09 2008-01-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
CA2691446C (en) * 2007-06-04 2021-07-06 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
KR20200022525A (ko) 2008-12-04 2020-03-03 충시 위 고투과력을 가진 조성물 및 이의 적용
KR102332837B1 (ko) 2012-01-18 2021-12-01 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU446324B2 (en) * 1971-02-04 1974-02-27 Beecham Inc. Chemical processes and products
BE787198A (fr) * 1971-08-07 1973-02-05 Merck Patent Gmbh Composes et melanges nematiques
JPS4954340A (de) * 1972-09-28 1974-05-27
IT1101712B (it) * 1978-11-16 1985-10-07 Bayer Italia Spa Procedimento perfezionato per la preparazione di guaiacolo acetil-salicilato
IT1144813B (it) * 1981-06-22 1986-10-29 Unione Chimica Medicamenti Dif Acetilsalicilato di 2 o metossi fenossi etanolo ad attivita analgesica antipiretica ed antiflogistica e suo metodo di preparazione
US4483854A (en) * 1983-04-12 1984-11-20 Key Pharmaceuticals, Inc. Systemic treatment of psoriasis using certain salicylates

Also Published As

Publication number Publication date
JPS6322541A (ja) 1988-01-30
IT1213579B (it) 1989-12-20
EP0251039B1 (de) 1991-09-18
ES2026485T3 (es) 1992-05-01
DE3773059D1 (de) 1991-10-24
IT8621021A0 (it) 1986-07-03
US4743704A (en) 1988-05-10
EP0251039A1 (de) 1988-01-07

Similar Documents

Publication Publication Date Title
DE68911103D1 (de) Verwendung von Fettsäuren zur Behandlung von myalgischer Enzephalomyelitis.
DK0606012T3 (da) Sammensætninger indeholdende cholesterylestere af umættede fedtsyrer
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
EP0602586A3 (de)
DK0563731T3 (da) Lægemidler indeholdende polyhydromethylenderivater, fremgangsmåde til deres fremstilling og deres anvendelse
DE69219602D1 (de) Pyrazolopyrimidin- und pyrimidinylbisphosphonsäureester als entzündungshemmende mittel
ATE81453T1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
DE3885151D1 (de) Methode zur Herstellung von Methacrylatestern.
ATE131154T1 (de) Phenylalkan(en)säuren.
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
ATE119770T1 (de) Verwendung von acetyl l-carnitin zur therapeutischen behandlung von coma.
ATE67479T1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
NO865132D0 (no) Sulfat-forestrede peptider.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
MY106615A (en) Stabilized leukocyte-interferons.
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE69006249D1 (de) Verfahren zur Herstellung von Carbonsäureestern und Formamid.
TW232014B (de)
ATE110720T1 (de) Verfahren zur herstellung von 2-mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren ester.
SU797665A1 (ru) Способ предупреждени постваго-ТОМичЕСКОгО гАСТРОСТАзА
DE69007706D1 (de) Verfahren zur Herstellung von Carbonsäureestern und Formamid.